New Year, New President, New Congress: How Might These Changes Affect ESRD?

What We Know: Costs of prescribed formulary drugs for those with Medicare Part D is capped at $2000. Clinics must provide phosphate binders to Medicare patients under the ESRD bundle and will be paid for them under the transitional drug add-on payment adjustment (TDAPA) for 2 years.
What We Don’t Know: Will doctors prescribe and clinics provide patients with the binders that work best for them? Will the Administration’s promise to cut federal agency staff and regulations impact patients and clinics? Will changes in immigration rules and visas affect foreign nephrologists, dialysis staff and patients?

Concurrent Care for Comfort Act Would Provide Separate Payment for Palliative Dialysis Posted 09-18-2026
MEI Comments on Proposed 2027 ESRD Payment and Quality Changes Posted 09-18-2026
H.R. 8875 “Improving Home Dialysis Act of 2026” would expand Medicare payment for temporary staff-assisted renal respite care and mental health services for eligible home dialysis patients. Posted 08-21-2026
H.R. 8319 Would Pay MDs for Remote Physiologic Monitoring of Home Dialysis Patients Posted 06-17-2026